Syneos Health_rgb_r.jpg
Syneos Health Releases 2022 Dealmakers’ Intentions Survey
11. Januar 2022 09:00 ET | Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released its 12th annual Dealmakers’...